Pain medicine: Palliative care section: A call for more research

Pain Medicine

Volumn 7, Issue 4, 2006, Pages 317-318

  Burton, Allen W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; GASTROINTESTINAL AGENT; LONG ACTING DRUG; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SHORT ACTING DRUG;

ANALGESIA; ANXIETY DISORDER; CANCER PAIN; CANCER PALLIATIVE THERAPY; CONFUSION; CONSTIPATION; DEEP VEIN THROMBOSIS; DEPRESSION; DISEASE SEVERITY; DRUG DOSE REGIMEN; EDITORIAL; FUNCTIONAL STATUS; HUMAN; INCIDENCE; MORBIDITY; NAUSEA; NERVE BLOCK; NEUROPATHIC PAIN; NOCICEPTION; PANCREAS CANCER; PERIPHERAL NEUROPATHY; PHANTOM PAIN; PNEUMONIA; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; PRURITUS; QUALITY OF LIFE; SEDATION; SIDE EFFECT; SITTING;

ANALGESICS; BIOMEDICAL RESEARCH; HUMANS; NEOPLASMS; PAIN; PALLIATIVE CARE; TERMINAL CARE; UNITED STATES;

EID: 33746304489     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2006.00190.x     Document Type: Editorial

References (13)

1. American Cancer Society. Cancer Facts and Figures. Atlanta: American Cancer Society, 2004.
2. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330: 592-6.
3. Gomez-Batiste X, Madrid F, Moreno F, et al. Breakthrough cancer pain: Prevalence and characteristics in patients in Catalonia, Spain. J Pain Symptom Manage 2002; 24: 45-52.
4. Grond S, Zech D, Diefenbach C, et al. Assessment of cancer pain: A prospective evaluation in 2,266 patients referred to a pain service. Pain 1996; 64: 107-14.
5. Clohisy DR, Mantyh PW. Bone cancer pain. Cancer 2003; 97: 866-73S.
6. Merskey H, ed. Classification of chronic pain: Description of chronic pain syndromes and definitions of pain terms. Pain 1986; 24 (suppl 1): S25-214.
7. Caraceni A, Zecca E, Martini C, De Conno F. Gabapentin as an adjuvant to opioids analgesia for neuopathic cancer pain. J Pain Symptom Manage 1999; 17: 441-5.
8. Bruera E, Pereira J, Watanabe S, et al. Opioid rotation in patients with cancer pain: A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer 1996; 78: 852-7.
9. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for abdominal pain associated with malignancy: A meta-analysis. Anesth Analg 1995; 80: 290-5.
10. Smith TJ, Staats PS, Deer T, et al. Randomized comparison of Intrathecal Drug Delivery System (IDDS) + Comprehensive Medical Management (CMM) vs. CMM alone for unrelieved cancer pain. J Clin Oncol 2002; 20: 4040-9.
11. Du Pen S, Kharasch ED, Williams A, et al. Chronic epidural bupivacaine-opioid infusion in intractable cancer pain. Pain 1992; 49: 293-300.
12. Burton AW, Rajagopal A, Shah HN, et al. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med 2004; 5: 239-47.
13. Burton AW, Reddy SK, Shah HN, Tremont-Lukas I, Mendel E. Percutaneous vertebroplasty - A technique to treat refractory spinal pain in the setting of advanced metastatic cancer: A case series. J Pain Symptom Manage 2005; 30: 87-95.